CRM Platform (Donor and Session Programme)

Description

NHS Blood and Transplant (NHSBT) is undertaking the Donor and Session Programme (DASP), a strategic transformation programme to modernise donor engagement, appointment booking, session management and related donor-facing and operational capabilities across blood, platelets and plasma. NHSBT has conducted a one-stage open procedure under the Procurement Act 2023 to establish a CRM Platform Framework supporting DASP. The CRM platform, referred to as the Donor Platform, is intended to provide the core platform capability required to support donor engagement, appointment management, session planning, operational responsiveness and future digital interoperability. Tender Responses were assessed in accordance with the published tender documents, including conditions of participation, mandatory technical capability requirements, Quality, Social Value and Commercial evaluation. The Framework is structured by CRM Platform using the Platform Tower model described in the tender documents. Tender Responses were grouped and evaluated within the relevant Platform Tower. NHSBT intends to appoint the highest-ranked compliant Supplier within each successful Platform Tower, subject to completion of the applicable standstill period and execution of the Framework Agreements. The Framework will provide a route through which NHSBT may award one planned Call-Off Contract without further competition. The potential Call-Off Contract would be awarded to the Framework Supplier appointed to the Platform Tower corresponding to the CRM Platform identified in the successful Technical Implementation Partner solution, in accordance with the objective Call-Off mechanism set out in the Framework documents. Appointment to the Framework does not oblige NHSBT to award a Call-Off Contract and does not guarantee any volume of work, revenue or expenditure. No CRM Call-Off Contract is being awarded through this Contract Award Notice. The Framework Agreement will have a maximum term of one (1) year with no option to extend and is intended to support the award of one Call-Off Contract only. Any Call-Off Contract must be awarded during the term of the Framework Agreement but may continue beyond expiry of the Framework. The potential Call-Off Contract will not exceed eight (8) years in total. For notice purposes, each provisional CRM Platform Tower lot has a potential value of up to £8,000,000 because the full planned Call-Off Contract may be awarded under the Platform Tower aligned with the successful Technical Implementation Partner solution. The lots are alternative routes to the same potential Call-Off requirement and are not cumulative. The total maximum value across the Framework and any Call-Off Contract will not exceed the published Contract Value. Unawarded Lots: Platform Tower 4, InVita CRM, has not been awarded. Unsuccessful supplier information: HEMATERRA TECHNOLOGIES UK LIMITED trading as InVita Healthcare Technologies; unique supplier identifier (PPON): PNZR-4766-PCZT; postal address: 267 Banbury Road, Oxford, OX2 7HT, United Kingdom; SME status: No; value-driven NGO status: No. Number of tenders assessed for this Platform Tower: 1.